P
Помните, как Тилю ЛГБТ активисты сказали, что он не тру-гей, если поддержал Трампа
Ivermectin is a “Safe, Effective, and Low-Cost” Way to Reduce COVID-19 Cases, New Peer-Reviewed Study Concludes
📝💊@COVID19Up@COVID19Up: Based on promising results of in vitro studies of oral ivermectin, a new study was conducted with the aim to demonstrate the prophylactic role of oral ivermectin in preventing SARS-CoV-2 infection among healthcare workers (HCWs) at the All India Institute of Medical Sciences (AIIMS) Bhubaneswar.
The results of the study, published August 5 in the peer-reviewed Cureus Journal of Medical Science, were as follows:
"Of 3892 employees, 3532 (90.8%) participated in the study. The ivermectin uptake was 62.5% and 5.3% for two doses and single dose, respectively. Participants who took ivermectin prophylaxis had a lower risk of getting symptoms suggestive of SARS-CoV-2 infection (6% vs 15%). HCWs who had taken two doses of oral ivermectin had a significantly lower risk of contracting COVID-19 infection during the following month (ARR 0.17; 95% CI, 0.12-0.23). Females had a lower risk of contracting COVID-19 than males (ARR 0.70; 95% CI, 0.52-0.93). The absolute risk reduction of SARS-CoV-2 infection was 9.7%. Only 1.8% of the participants reported adverse events, which were mild and self-limiting."
The study concludes:
"Two doses of oral ivermectin (300 μg/kg/dose given 72 hours apart) as chemoprophylaxis among HCWs reduced the risk of COVID-19 infection by 83% in the following month. Safe, effective, and low-cost chemoprophylaxis has relevance in the containment of pandemic alongside vaccine."
➔ COVID19Up.org for more!
Join the discussion:
➔ 🗣@COVID1984Chat@COVID1984Chat
